vs
Side-by-side financial comparison of APPIAN CORP (APPN) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
APPIAN CORP is the larger business by last-quarter revenue ($202.9M vs $168.4M, roughly 1.2× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 21.7%). Over the past eight quarters, APPIAN CORP's revenue compounded faster (16.4% CAGR vs 10.6%).
Appian Corporation is an American cloud computing and enterprise software company headquartered in McLean, Virginia, part of the Dulles Technology Corridor. The company sells a platform as a service (PaaS) for building enterprise software applications. It is focused on low-code development, process mining, business process management, and case management markets in North America, Europe, the Middle East and Southeast Asia.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
APPN vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $202.9M | $168.4M |
| Net Profit | $-5.1M | — |
| Gross Margin | 64.8% | — |
| Operating Margin | -0.3% | 50.6% |
| Net Margin | -2.5% | — |
| Revenue YoY | 21.7% | 143.7% |
| Net Profit YoY | 62.6% | — |
| EPS (diluted) | $-0.06 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $202.9M | $168.4M | ||
| Q3 25 | $187.0M | $87.3M | ||
| Q2 25 | $170.6M | $82.4M | ||
| Q1 25 | $166.4M | $65.0M | ||
| Q4 24 | $166.7M | $69.1M | ||
| Q3 24 | $154.1M | $51.6M | ||
| Q2 24 | $146.4M | $73.8M | ||
| Q1 24 | $149.8M | $137.7M |
| Q4 25 | $-5.1M | — | ||
| Q3 25 | $7.8M | $-31.3M | ||
| Q2 25 | $-312.0K | $-12.7M | ||
| Q1 25 | $-1.2M | $-40.5M | ||
| Q4 24 | $-13.6M | — | ||
| Q3 24 | $-2.1M | $-29.5M | ||
| Q2 24 | $-43.6M | $-61.9M | ||
| Q1 24 | $-32.9M | $61.0M |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 75.8% | — | ||
| Q2 25 | 74.3% | — | ||
| Q1 25 | 76.6% | — | ||
| Q4 24 | 67.8% | — | ||
| Q3 24 | 75.9% | — | ||
| Q2 24 | 73.1% | — | ||
| Q1 24 | 74.6% | — |
| Q4 25 | -0.3% | 50.6% | ||
| Q3 25 | 7.0% | -11.4% | ||
| Q2 25 | -6.4% | 8.6% | ||
| Q1 25 | -0.5% | -34.0% | ||
| Q4 24 | 3.0% | -6.4% | ||
| Q3 24 | -4.6% | -31.0% | ||
| Q2 24 | -26.8% | 3.5% | ||
| Q1 24 | -13.0% | 52.5% |
| Q4 25 | -2.5% | — | ||
| Q3 25 | 4.2% | -35.9% | ||
| Q2 25 | -0.2% | -15.4% | ||
| Q1 25 | -0.7% | -62.2% | ||
| Q4 24 | -8.2% | — | ||
| Q3 24 | -1.4% | -57.2% | ||
| Q2 24 | -29.8% | -83.9% | ||
| Q1 24 | -22.0% | 44.3% |
| Q4 25 | $-0.06 | $0.32 | ||
| Q3 25 | $0.10 | $-0.16 | ||
| Q2 25 | $0.00 | $-0.06 | ||
| Q1 25 | $-0.02 | $-0.21 | ||
| Q4 24 | $-0.18 | $-0.14 | ||
| Q3 24 | $-0.03 | $-0.15 | ||
| Q2 24 | $-0.60 | $-0.33 | ||
| Q1 24 | $-0.45 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | $167.9M |
| Total DebtLower is stronger | $240.8M | — |
| Stockholders' EquityBook value | $-47.0M | $-302.0M |
| Total Assets | $691.4M | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | $167.9M | ||
| Q3 25 | $191.6M | $92.4M | ||
| Q2 25 | $184.8M | $86.1M | ||
| Q1 25 | $199.7M | $114.6M | ||
| Q4 24 | $159.9M | $144.8M | ||
| Q3 24 | $99.2M | $144.7M | ||
| Q2 24 | $120.8M | $189.3M | ||
| Q1 24 | $170.1M | $226.6M |
| Q4 25 | $240.8M | — | ||
| Q3 25 | $245.7M | — | ||
| Q2 25 | $245.6M | — | ||
| Q1 25 | $248.0M | — | ||
| Q4 24 | $250.4M | — | ||
| Q3 24 | $252.8M | — | ||
| Q2 24 | $254.0M | — | ||
| Q1 24 | $255.1M | — |
| Q4 25 | $-47.0M | $-302.0M | ||
| Q3 25 | $-48.5M | $-451.4M | ||
| Q2 25 | $-53.7M | $-433.5M | ||
| Q1 25 | $-31.7M | $-426.2M | ||
| Q4 24 | $-32.6M | $-388.7M | ||
| Q3 24 | $-49.8M | $-370.2M | ||
| Q2 24 | $-45.7M | $-344.2M | ||
| Q1 24 | $-9.7M | $-294.3M |
| Q4 25 | $691.4M | $465.9M | ||
| Q3 25 | $611.7M | $364.0M | ||
| Q2 25 | $590.7M | $347.1M | ||
| Q1 25 | $592.9M | $324.0M | ||
| Q4 24 | $621.0M | $343.8M | ||
| Q3 24 | $549.9M | $314.1M | ||
| Q2 24 | $554.6M | $352.3M | ||
| Q1 24 | $595.4M | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1M | $45.2M |
| Free Cash FlowOCF − Capex | $270.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $45.2M | ||
| Q3 25 | $18.7M | $-4.3M | ||
| Q2 25 | $-1.9M | $-31.4M | ||
| Q1 25 | $45.0M | $-22.6M | ||
| Q4 24 | $13.9M | $-35.0M | ||
| Q3 24 | $-8.2M | $-35.3M | ||
| Q2 24 | $-17.6M | $-7.2M | ||
| Q1 24 | $18.9M | $53.8M |
| Q4 25 | $270.0K | — | ||
| Q3 25 | $18.1M | — | ||
| Q2 25 | $-3.1M | — | ||
| Q1 25 | $44.3M | — | ||
| Q4 24 | $13.4M | — | ||
| Q3 24 | $-8.6M | $-35.5M | ||
| Q2 24 | $-18.3M | $-7.3M | ||
| Q1 24 | $16.7M | $53.8M |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | -1.8% | — | ||
| Q1 25 | 26.6% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | -5.6% | -68.7% | ||
| Q2 24 | -12.5% | -9.9% | ||
| Q1 24 | 11.1% | 39.0% |
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.4% | 0.0% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.5% | 0.1% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.39× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APPN
| Subscriptions Software And Support | $162.3M | 80% |
| Professional Services | $40.6M | 20% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
